Saturday, November 16, 2024
HomeTagsR/r B-cell ALL

r/r B-cell ALL

Cellectis Announces First Dosing of a Patient with its In-house Manufactured Product Candidate UCART22

Cellectis, a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, announced that for the first time, a...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics